Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Spillmann

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
European Heart Journal|March 21, 2019
Mode-of-action of the PROPELLA concept in fulminant myocarditisFrank Spillmann, Sophie Van Linthout, Gunther Schmidt, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 25, 2021
First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in GermanyAlexander M Bernhardt, Evgenij Potapov, David Schibilsky, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 26, 2010
Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammationSophie Van Linthout, Frank Spillmann, Gallia Graiani, et al.
Circulation. Heart Failure|September 16, 2017
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced MyocarditisCarsten Tschöpe, Irene Müller, Yu Xia, et al.
European Journal of Heart Failure|September 12, 2017
Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)Tobias Daniel Trippel, Sophie Van Linthout, Dirk Westermann, et al.
Circulation|March 12, 2008
Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathySophie Van Linthout, Frank Spillmann, Alexander Riad, et al.
The Journal of Infectious Diseases|March 26, 2015
Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With CardiomyopathyCaroline Schmidt-Lucke, Thomas Zobel, Sonja Schrepfer, et al.
Nature Reviews. Cardiology|October 13, 2020
Myocarditis and inflammatory cardiomyopathy: current evidence and future directionsCarsten Tschöpe, Enrico Ammirati, Biykem Bozkurt, et al.
Resuscitation|March 23, 2023
Left-ventricular unloading in extracorporeal cardiopulmonary resuscitation due to acute myocardial infarction - A multicenter studyTharusan Thevathasan, Megan A Kenny, Finn J Krause, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Heart Journal|March 21, 2019
Mode-of-action of the PROPELLA concept in fulminant myocarditisFrank Spillmann, Sophie Van Linthout, Gunther Schmidt, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 25, 2021
First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in GermanyAlexander M Bernhardt, Evgenij Potapov, David Schibilsky, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 26, 2010
Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammationSophie Van Linthout, Frank Spillmann, Gallia Graiani, et al.
Circulation. Heart Failure|September 16, 2017
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced MyocarditisCarsten Tschöpe, Irene Müller, Yu Xia, et al.
European Journal of Heart Failure|September 12, 2017
Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)Tobias Daniel Trippel, Sophie Van Linthout, Dirk Westermann, et al.
Circulation|March 12, 2008
Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathySophie Van Linthout, Frank Spillmann, Alexander Riad, et al.
The Journal of Infectious Diseases|March 26, 2015
Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With CardiomyopathyCaroline Schmidt-Lucke, Thomas Zobel, Sonja Schrepfer, et al.
Nature Reviews. Cardiology|October 13, 2020
Myocarditis and inflammatory cardiomyopathy: current evidence and future directionsCarsten Tschöpe, Enrico Ammirati, Biykem Bozkurt, et al.
Resuscitation|March 23, 2023
Left-ventricular unloading in extracorporeal cardiopulmonary resuscitation due to acute myocardial infarction - A multicenter studyTharusan Thevathasan, Megan A Kenny, Finn J Krause, et al.
Pageof 6